Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Graalum

90 clinical trials in Graalum, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Graalum at a glance
90
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

90 trials in Graalum

Open in trial search

Crohn's disease

Recruiting

Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Safety and Pharmacodynamics of RBD4059 and Apixaban in Patients with Non‑Valvular Atrial Fibrillation: A Randomized Active‑Controlled Study

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Ribocure Pharmaceuticals AB

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC

Anaemia+1

Recruiting

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.

Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Phase II Study of Teclistamab Plus Pomalidomide in Patients with Relapsed/Refractory Multiple Myeloma After 1–3 Prior Therapies

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Pomalidomide
  • Sponsor:Odense University Hospital

Pumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

A study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:Boehringer Ingelheim International GmbH

Study of Izalontamab Brengitecan Compared to Platinum-Based Chemotherapy for Patients with Metastatic Urothelial Cancer After Immunotherapy

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Graalum

What the registry says about research in the country

01 Diseases of the Digestive System

Clinical research in this area focuses on digestive system diseases, especially low anterior resection syndrome after surgery for rectal cancer. The trials in Grålum aim to better understand symptom relief and improve quality of life for people living with ongoing bowel problems.

  • Evaluating a treatment intended to reduce the burden of LARS symptoms
  • Studying symptom control after rectal cancer surgery

This work supports better management of postoperative bowel dysfunction and patient comfort.

02 Diseases of the Nervous System

Research in nervous system diseases is centered on acute ischemic stroke, with attention to whether early treatment can improve neurological recovery. The goal is to compare treatment approaches and strengthen care for patients facing urgent stroke events.

  • Assessing early neurological improvement after stroke treatment
  • Comparing outcomes in patients with acute ischemic stroke

These trials are designed to refine stroke treatment and support faster recovery.

03 Viral Diseases and Respiratory Infections

A major focus in virus diseases is viral respiratory tract infection, where investigators are testing whether stopping antibiotics is safe when a respiratory virus has been confirmed. This research helps guide more appropriate treatment and reduce unnecessary antibiotic use.

  • Evaluating antibiotic discontinuation in viral respiratory illness
  • Testing treatment decisions for patients with positive respiratory virus samples

The study supports smarter infection management and better antibiotic stewardship.

04 Pathological Conditions, Signs and Symptoms

Research in pathological conditions, signs and symptoms connects several of the local studies by focusing on how symptoms change with treatment. In this small but active research setting, the emphasis is on practical benefits for patients rather than broad experimental complexity.

  • Measuring symptom burden as a key outcome
  • Tracking improvement in everyday health problems

The trials aim to show whether current approaches can ease symptoms more effectively and safely.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.